Nirmatrelvir/Ritonavir Added to Ninth Update of WHO’s Living Guideline on COVID-19 Therapeutics
In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.